OCT 20, 2020 3:30 PM PDT

Should Cannabis Doses Be Standardized?

WRITTEN BY: Annie Lennon

Should cannabis and its compounds such as tetrahydrocannabinol (THC), the psychoactive compound in cannabis, come in standardized doses? While it may benefit both cannabis research and cannabis-related treatments, the nature of the plant makes it difficult to properly standardize. 

The National Institute of Drug Abuse (NIDA) recently released a Request for Information (RIF) for a Standard Unit Dose of THC for cannabis research. In particular, the agency said wants to look into creating a standardized dose similar to that for alcohol, tobacco, and opioids both for researchers to more effectively analyze its properties and for users to better understand how to consume it. 

Despite its possible benefits, standardizing doses of THC may not standardize its effects. There is a growing body of evidence, for example, showing that the effects of cannabinoids depend on how they react with others present in the cannabis plant. This means that while cannabis varieties contain the same amount of THC, their effects may differ due to the other active cannabinoids, terpenes, etc. in the plant too. 

More than this, delivery methods of cannabis products can also impact the effects of THC, as well as how they are absorbed and metabolized. 

“There’s a difference between 10mg of THC that’s inhaled, which is actually a very big dose if someone is actually getting that much, and 10mg taken orally, which is going to affect some people who don’t have tolerance quite markedly, but the time contours are totally different,” says Dr. Ethan Russo, in an episode of The Cannabis Enigma podcast.

“It also depends on endocannabinoid tone, a patient’s prior experience, do they have tolerance to the material or not?”

As such, despite the potential benefits to both patients and research standardizing THC doses may bring, making this happen in practice could be a challenging feat. While this does not mean it should not be attempted, it does mean that many factors must be taken into account during implementation. 

 

Sources: The CannigmaWiley Online Library

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 06, 2020
Cannabis Sciences
Cannabis Use May Reduce Cancer Risk by 10%
OCT 06, 2020
Cannabis Use May Reduce Cancer Risk by 10%
A recent meta-analysis of 34 studies found that cannabis use may decrease one’s risk of developing certain kinds o ...
OCT 14, 2020
Health & Medicine
Sanobiotec Produces Reliable THCV
OCT 14, 2020
Sanobiotec Produces Reliable THCV
Lithuania-based bio Sanobiotec has joined a band of biotech companies moving into the synthetic cannabinoid market and a ...
NOV 01, 2020
Cannabis Sciences
Can Cannabis Treat ALS?
NOV 01, 2020
Can Cannabis Treat ALS?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative illness that damages motor neurons and leads to progressive m ...
NOV 05, 2020
Health & Medicine
Medical Cannabis Reduces Chronic Pain and Opioid Use
NOV 05, 2020
Medical Cannabis Reduces Chronic Pain and Opioid Use
Researchers affiliated with the University of Haifa in Israel have reported on the efficacy of medical cannabis use for ...
NOV 14, 2020
Cannabis Sciences
Half of CBD Users Test Positive for THC in Urine Tests
NOV 14, 2020
Half of CBD Users Test Positive for THC in Urine Tests
Despite the growing popularity of cannabidiol (CBD) products, there has been little research directly assessing whether ...
DEC 01, 2020
Cannabis Sciences
CBD Does Not Effect Driving Ability, THC Wears Off in 4 Hours
DEC 01, 2020
CBD Does Not Effect Driving Ability, THC Wears Off in 4 Hours
Researchers from the Lambert Initiative at the University of Sydney, have found that cannabidiol, a medically active com ...
Loading Comments...